Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Adenoviral vector bearing gene for p53 data

Introgen and partner RPR Gencell (Collegeville, Penn.) announced that early trials show the ability of an adenoviral vector to deliver the p53 gene to tumors, with

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE